When women stop taking glucagon-like peptide-1 (GLP-1) drugs like Ozempic or Wegovy, they regain approximately 60% of the weight they lost within one year, according to new research from the University of Cambridge. However, the pace of weight regain slows over time, and roughly 25% of the original weight loss is expected to be retained long-term. This finding challenges the idea that these medications offer a permanent solution and highlights the importance of lifestyle changes alongside medication. What Happens After You Stop Taking GLP-1 Drugs? Researchers at the University of Cambridge analyzed 48 previous studies, including 36 randomized controlled trials and 12 non-randomized studies, to understand what happens when people discontinue GLP-1 medications. The team focused on six trials involving more than 3,200 participants that tracked patients for up to 52 weeks after stopping treatment. The findings, published in the journal eClinicalMedicine, reveal a predictable pattern of weight regain. The weight regain happens most rapidly in the first few months after stopping medication. By the end of 52 weeks, people had regained nearly 60% of the weight they had lost. After nearly 60 weeks, the regain began to level off, suggesting that the body eventually reaches a new equilibrium. For example, someone who lost 20% of their body weight while taking the medication might still maintain a weight that is 5% below their starting weight after stopping the medication. Why Does Weight Come Back So Quickly? GLP-1 receptor agonists work by mimicking a natural hormone your body makes after eating. These medications slow stomach emptying, stabilize blood sugar, and signal your brain that you've had enough food. When you stop taking them, appetite returns and your body tries to regain the weight it lost. "Drugs such as Ozempic and Wegovy act like brakes on our appetite, making us feel full sooner, which means we eat less and therefore lose weight. When people stop taking them, they are essentially taking their foot off the brake, and this can lead to rapid weight regain," explains Brajan Budini, a medical student at the University of Cambridge and one of the study's authors. The regain isn't just about appetite returning. Researchers noted that it remains unclear whether the regained weight is mainly fat or includes muscle. Previous studies have suggested that up to 40% of the weight loss during treatment is lean body mass, including muscle, which means some of the regained weight could be muscle tissue rather than fat. How to Maintain Weight Loss After Stopping GLP-1 Medications - Combine medication with lifestyle changes: Long-term success cannot rely on medication alone. Patients need nutrition support, physical activity, sleep, and regular medical follow-up to maintain weight loss after discontinuing GLP-1 drugs. - Build sustainable eating habits during treatment: Use the period while taking GLP-1 medications to establish new eating patterns, such as smaller portions, more protein intake, and structured meals that can persist after stopping the drug. - Maintain regular physical activity: Consistent exercise helps preserve muscle mass and metabolic function, which is especially important since up to 40% of weight loss during GLP-1 treatment may be lean body mass. - Prioritize sleep and stress management: Sleep debt and chronic stress can increase appetite and make it easier to regain weight, so these factors deserve as much attention as diet and exercise. - Schedule ongoing medical supervision: Regular check-ins with healthcare providers allow for early intervention if weight regain accelerates and help adjust strategies based on individual needs. Dr. Dheeraj Kapoor, head of endocrinology at Kokilaben Dhirubhai Ambani Hospital in Mumbai, emphasizes that obesity should be treated as a chronic disease rather than a short-term condition. "Long-term success cannot rely on medication alone. Patients need nutrition support, physical activity, sleep and regular medical follow-up," Dr. Kapoor said. The Real-World Timeline: What to Expect Over 6-12 Months For women considering or currently using GLP-1 medications, understanding the realistic timeline can help set appropriate expectations. The first few weeks are often about adjusting to the injection routine and managing mild side effects like nausea. Early changes might be subtle: a couple of pounds, less snacking, and reduced evening food cravings. Many people expect dramatic weight loss in the first month, but in reality, these early changes can feel anticlimacticâthough also oddly peaceful. By months 3-6, the injection becomes a once-a-week habit and choices feel easier. It's not that you suddenly love salad; it's that saying "no" to extra servings doesn't feel like a war. Weight changes during this period are often noticeableâperhaps 5-10% of body weight over several months, especially with healthy eating and movement. Research on semaglutide for weight management shows average weight loss in the 10-15% range over about a year when combined with lifestyle changes. By months 6-12, new baseline habits often develop naturally. You might gravitate toward smaller portions, more protein, and more structured meals. Food becomes less of a constant mental background noise. However, weight loss often slows or pauses during this period, which is normal but can be frustrating. Throughout this time, life continues with vacations, stress at work, and family demands. GLP-1 medications don't remove these challenges, but many women describe feeling like they're finally on their own side. Why Treating Obesity as a Chronic Condition Matters The Cambridge study's findings shine a light on the significance of long-term care and lifestyle support for people using weight-loss drugs. Obesity and related metabolic diseases are rising steadily, with an estimated 135 million people in India living with diabetes alone. According to the National Family Health Survey (2019-21), 24% of women and 23% of men in India are overweight or obese. As the patent for semaglutide expires in March 2026, cheaper generic versions are expected to enter the market, potentially making these medications more accessible. However, accessibility without proper support systems could lead to widespread disappointment if people expect permanent weight loss without ongoing lifestyle management. Dr. Sharma, an endocrinologist at Aakash Healthcare Super Speciality Hospital, notes that maintaining weight loss usually requires a combination of medication, dietary changes, regular exercise, and ongoing medical supervision. The key takeaway is that GLP-1 medications like Ozempic and Wegovy are tools, not cures. They can help women over 40 address the biological challenges that make weight loss harderâhormonal shifts, insulin resistance, and appetite dysregulationâbut they work best as part of a comprehensive approach that includes sustainable lifestyle changes. Understanding that roughly 25% of weight loss can be maintained long-term, even after stopping medication, offers realistic hope for women seeking to manage their weight effectively.
